Effects of MS-8209, an amphotericin B derivative, on tumor necrosis factor alpha synthesis and human immunodeficiency virus replication in macrophages

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 2, 2000, Pages 405-407

  Clayette, Pascal ^a,b   Martin, Marc ^a   Beringue, Vincent ^a   Dereuddre Bosquet, Nathalie ^a,b   Adjou, Karim T ^a,c   Seman, Michel ^d   Dormont, Dominique ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^b SPI BIO   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d Laboratoires Mayoly Spindler   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DERIVATIVE; ANTIRETROVIRUS AGENT; MESSENGER RNA; MS 8209; RNA DIRECTED DNA POLYMERASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRAIN DIFFERENCE; VIRUS REPLICATION;

AMPHOTERICIN B; ANTI-HIV AGENTS; HIV; HUMANS; MACROPHAGES; RISK FACTORS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 0033969286     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.2.405-407.2000     Document Type: Article

References (19)

1. Benveniste, O., M. Martin, F. Villinger, and D. Dormont. 1998. Techniques for quantification of cytokine mRNAs. Cytokines Cell. Mol. Ther. 4:207-214.
2. Brajtburg, J., S. Elberg, G. S. Kobayashi, and G. Medoff. 1986. Toxicity and induction of resistance to Listeria monocytogenes infection by amphotericin B in inbred strains of mice. Infect. Immun. 54:303-307.
3. Brennan, P., and L. A. J. O'Neill. 1995. Effects of oxidants and antioxidants on nuclear factor κB activation in three different cell lines: evidence against a universal hypothesis involving oxygen radicals. Biochim. Biophys. Acta 1260:167-175.
4. Cefai, D., F. Hadida, M. Jung, P. Debré, J. G. Vernin, and M. Seman. 1991. MS-8209, a new amphotericin B derivative that inhibits HIV-1 replication in vitro and restores T-cell activation via the CD3/TcR in HIV-infected CD4+ cells. AIDS 5:1453-1461.
5. Clayette, P., M. Dereuddre-Bosquet, M. Martin, P. Fretier, and D. Dormont. 1997. Effects of RP55778, a tumor necrosis factor alpha synthesis inhibitor, on antiviral activity of dideoxynucleosides. Antimicrob. Agents Chemother. 41:875-877.
6. DeLuca, C., H. Kwon, N. Pelletier, M. A. Wainberg, and J. Hiscott. 1998. NF-kappaB protects HIV-1-infected myeloid cells from apoptosis. Virology 244:27-38.
7. Dereuddre-Bosquet, N., P. Clayette, M. Martin, O. Benveniste, P. Fretier, P. Jaccard, B. Vaslin, A. Lebeaut, and D. Dormont. 1997. Lack of interleukin-10 expression in monocyte-derived macrophages in response to in vitro infection by HIV type 1 isolates. AIDS Res. Hum. Retrovir. 13:961-965.
8. Duval, X., P. Clayette, N. Dereuddre-Bosquet, P. Fretier, M. Martin, D. Salmon-Céron, G. Gras, J. L. Vildé, and D. Dormont. 1997. Dapsone and HIV-1 replication in primary cultures of lymphocytes and monocyte-derived macrophages. AIDS 11:943-944.
9. Leseth, K. H., M. Adner, H. K. Berg, L. R. White, J. Aasly, and L. Edvinsson. 1999. Cytokines increase endothelin ETB receptor contractile activity in rat cerebral artery. Neuroreport 10:2355-2359.
10. Louie, A., A. Baltch, M. Franke, R. Smith, and M. Gordon. 1994. Comparative capacity of four antifungal agents to stimulate murine macrophages to produce tumor necrosis factor alpha: an effect that is attenuated by pentoxifylline, liposomal vesicles, and dexamethasone. J. Antimicrob. Chemother. 34:975-987.
11. Maglerowska-Jung, M., D. Cefai, H. Marrakchi, F. Chieze, H. Agut, J. M. Huraux, and M. Seman. 1996. In vitro determination of antiviral activity of MS-8209, a new amphotericin B derivative, against primary isolates of HIV-1. Res. Virol. 147:313-318.
12. Perry, S. W., J. A. Hamilton, L. W. Tjoelker, G. Dbaibo, K. A. Dzenko, L. G. Epstein, Y. Hannun, J. S. Whittaker, S. Dewhurst, and H. A. Gelbard. 1998. Platelet-activating factor receptor activation. An initiator step in HIV-1 neuropathogenesis. J. Biol. Chem. 273:17660-17664.
13. Pleskoff, O., M. Seman, and M. Alizon. 1995. Amphotericin B derivative blocks human immunodeficiency virus type 1 entry after CD4 binding: effect on virus-cell fusion but not on cell-cell fusion. J. Virol. 69:570-574.
14. Poli, G., A. Kinter, J. Justement, J. Kerhrl, P. Bressler, S. Stanley, and A. Fauci. 1990. Tumor necrosis factor alpha function in an autocrine manner in the induction of human immunodeficiency virus expression. Proc. Natl. Acad. Sci. USA 87:782-785.
15. Rogers, D. P., J. K. Jenkins, S. W. Chapman, K. Ndebele, B. A. Chapman, and J. D. Cleary. 1998. Amphotericin B activation of human genes encoding for cytokines. J. Infect. Dis. 178:1726-1733.
16. Salmon-Céron, D., A. Fontbonne, J. Saba, T. May, F. Raffi, C. Chidiac, O. Patey, J. P. Aboulker, D. Schwartz, and J. L. Vildé. 1995. Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. J. Infect. Dis. 172:656-664.
17. Tokuda, Y., M. Tsuji, M. Yamazaki, S. Kimura, S. Abe, and H. Yamaguchi. 1993. Augmentation of murine tumor necrosis factor production by amphotericin B in vitro and in vivo. Antimicrob. Agents Chemother. 37:2228-2230.
18. van der Horst, C. M., M. S. Saag, G. A. Cloud, R. J. Hamill, J. R. Graybill, J. D. Sobel, P. C. Johnson, C. U. Tuazon, T. Kerkering, B. L. Moskovitz, W. G. Powderly, and W. E. Dismukes. 1997. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N. Engl. J. Med. 337:15-21.
19. Vyakarnam, A., J. McKeating, A. Meager, and P. Beverley. 1990. Tumor necrosis factor (α, β) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication. AIDS 4:21-27.